TMO vs ABT
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | ABT |
|---|---|---|
| Price | $700.22 | $108.52 |
| Market cap | $259.44B | $187.95B |
| P/E ratio | 36.9 | 40.5 |
| ROE | 13.38% | 9.14% |
| Profit margin | 14.94% | 9.75% |
| Revenue growth | 9.10% | 14.50% |
| Dividend yield | 0.27% | 2.32% |
| Beta | 0.84 | 0.54 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs ABT in plain English
- TMO is the bigger company — about 1.4× the market cap of ABT.
- TMO is cheaper on earnings (P/E 36.9 vs 40.5).
- TMO earns a higher return on equity (13% vs 9%).
- ABT is growing revenue faster (14% vs 9%).
- ABT has the higher dividend yield (2.32% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.